Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...

One such example is Novo Nordisk (NYSE: NVO), the Denmark-based pharmaceutical leader whose shares are exchanging hands for ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, ...

The MOU marks a significant step in strengthening the Kingdom’s healthcare sector and pharmaceutical manufacturing ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...